Covista Inc. (CVSA) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary.

Total Revenue Chart for Covista Inc.

Covista Inc. (CVSA) revenue for FY2026 was USD 2.0B, a 9.3% change from FY2025. Covista Inc.'s revenue grew from USD 153.7M in 1989 to USD 2.0B in 2026 (1171.4% over 37 years). Earnings per share grew from USD 0.68 in 2000 to USD 2.05 in 2023 (201.1%). Revenue compound annual growth rate: 5-year CAGR of 16.6%, 10-year CAGR of 0.6%, 20-year CAGR of 4.3%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$4.46B
Implied Share Price
$131.82
Enterprise Value
$4.80B
Revenue (TTM)
$1.95B
EBITDA
$444.78M
Profit Margin
12.87%
Trailing P/E
17.60
Forward P/E
13.97
Price/Book (MRQ)
2.98
Price/Sales (TTM)
2.28
EV/EBITDA
10.28
EV/Revenue
2.46
Dividend Yield
—
Book Value
$42.49
Free Cash Flow (FY2026)
$392.73M
Free Cash Flow Yield
8.80%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.